AKT1 and prostate carcinoma: The enrichment pathways identified following KEGG analysis that contained the most core targets included prostate cancer, proteoglycans in cancer, adherens junction, the PI3K-Akt signaling pathway, the MAPK signaling pathway, and more (Figure S9B).